THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Genzyme shifting work from Allston plant

Contamination woes are cited for move; jobs won’t be affected

Genzyme entered into an agreement with drug maker Hospira Inc. to take over the so-called filling and finishing process. Genzyme entered into an agreement with drug maker Hospira Inc. to take over the so-called filling and finishing process. (Bizuayehu Tesfaye/ Associated Press/ File 2008)
By Megan Woolhouse
Globe Staff / January 5, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

Cambridge biotechnology company Genzyme Corp. will move all its filling, packaging, and distribution operations out of its Allston drug manufacturing facility because of the latest problems involving contamination at the plant. (Full article: 554 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly